MONROE TOWNSHIP, N.J., April 30, 2025 ( GLOBE NEWSWIRE ) -- Ocean Power Technologies, Inc.

NEWPORT NEWS, Va., April 30, 2025 ( GLOBE NEWSWIRE ) -- HII HII announced today that its Board of Directors has declared a quarterly cash dividend of $1.35 per share, payable on June 13, 2025, to shareholders of record as of the close of business on May 30, 2025.

Key takeaways:Macro Chain Index issues first buy signal since 2022, hinting at a new Bitcoin bull run.RSI crossover on the MCI aligns with past cycle bottoms that preceded 500%+ BTC rallies.Bitcoin price recovers from $74K to $95K amid rising open interest and positive funding rates.A key ...

KISSIMMEE, Fla., April 30, 2025 ( GLOBE NEWSWIRE ) -- ECD Auto Design ECDA, the world's leading creator of restored Land Rovers and custom classic vehicles, proudly debuts Project Beach Patrol, a Defender 90 soft top built for warm weather, relaxed cruising, and statement-making style-all ...

LONDON, ON, April 30, 2025 /CNW/ - Canada Life Investment Management Ltd. ( CLIML ) today announced a sub-advisor change to the Canada Life Global Small-Mid Cap Equity Fund ( the "Fund" ) .

WALTHAM, Mass., April 30, 2025 ( GLOBE NEWSWIRE ) -- Sionna Therapeutics, Inc. ( Nasdaq: SION ) , a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis ( CF ) by developing novel medicines that normalize the function of the ...

MONTREAL, April 30, 2025 /CNW/ - TVA Group Inc. will hold its Annual Meeting of Shareholders as a live audio webcast on Tuesday, May 6, 2025 at 11:00 a.m. The question period during the meeting will be reserved for shareholders.

NEW YORK, April 30, 2025 ( GLOBE NEWSWIRE ) -- OTC Markets Group Inc. OTCM, operator of regulated markets for trading 12,000 U.S. and international securities, today announced Velo3D, Inc.

TEL AVIV, Israel, April 30, 2025 ( GLOBE NEWSWIRE ) -- Gauzy Ltd. ( NASDAQ:GAUZ ) ( "Gauzy" or the "Company" ) , a global leader in light and vision control technologies, today announced it will release financial results for the first quarter ended March 31, 2025, before the market opens on ...

LONDON and NEW YORK, April 30, 2025 ( GLOBE NEWSWIRE ) -- OKYO Pharma Limited ( NASDAQ: OKYO ) , an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod ( formerly called OK-101 ) to treat NCP, an ocular condition associated with chronic and often severe pain but ...